Nicholas David Peter Cosford

This inventor holds 15 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Sanford Burnham Prebys Medical Discovery Institute, Sanford-Burnham Medical Research Institute, The Salk Institute. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas David Peter Cosford. Retrieved from https://idiyas.com/inventor/nicholas-david-peter-cosford

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 3)

% Patents Active = 93.3

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 48(Granted Patents)

Location History:

La Jolla, CA (US) (2017 - 2021)
San Diego, CA (US) (2004 - 2024)

Company Filing History:

11 out of 99

Sanford Burnham Prebys Medical Discovery Institute

patents

3 out of 99

Sanford-Burnham Medical Research Institute

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12729208 - Inhibitor of apoptosis (IAP) protein antagonists (2026-09-08),

2. 12678509 - Inhibitor of apoptosis (IAP) protein antagonists (2026-07-14),

3. 12637436 - Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof (2026-05-26),

4. 12465594 - Compositions and methods for the modulation of the corticotropin releasing factor binding protein and the treatment of alcohol use disorder (2025-11-11),

5. 11912786 - Inhibitor of apoptosis protein (IAP) antagonists (2024-02-27),

6. 11447453 - Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof (2022-09-20),

7. 11111270 - Inhibitor of apoptosis protein (IAP) antagonists (2021-09-07),

8. 10864217 - Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy (2020-12-15),

9. 10597367 - Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof (2020-03-24),

10. 10544188 - Inhibitor of apoptosis protein (IAP) antagonists (2020-01-28),

11. 10300074 - Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy (2019-05-28),

12. 10047119 - Inhibitor of apoptosis protein (IAP) antagonists (2018-08-14),

13. 9969726 - Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof (2018-05-15),

14. 9546174 - Inhibitor of apoptosis protein (IAP) antagonists (2017-01-17),

15. 6774138 - Thiazolyl(pyridyl)ethyne compounds (2004-08-10),

Title: The Innovative Contributions of Nicholas David Peter Cosford

Introduction

Nicholas David Peter Cosford is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of medical research, holding a total of 11 patents. His work focuses on developing compounds that have the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents are the inhibitors of apoptosis protein (IAP) antagonists. These compounds are designed to modulate the activity of inhibitor of apoptosis proteins, providing new avenues for treatment. Another notable patent involves metabotropic glutamate receptor negative allosteric modulators (NAMs). These small molecules target metabotropic glutamate subtype-2 and -3 receptors, offering innovative methods for their application in medical treatments.

Career Highlights

Cosford has worked with esteemed institutions such as the Sanford Burnham Prebys Medical Discovery Institute and the Sanford Burnham Medical Research Institute. His career has been marked by a commitment to advancing medical science through innovative research and development.

Collaborations

Some of his notable coworkers include Mitchell Dennis Vamos and Dhanya Raveendra-Panickar. Their collaborative efforts have contributed to the success of various projects and patents.

Conclusion

Nicholas David Peter Cosford's work exemplifies the spirit of innovation in the medical field. His patents and collaborations highlight his dedication to advancing healthcare through scientific discovery.

Profile summary based on public USPTO records.